A patient with relapsed high-grade serous ovarian carcinoma with somatic RAD51C mutations treated with PARPi monotherapy: a case report

We report our experience in the management of a relapsed ovarian cancer patient with somatic RAD51C mutation, treated with olaparib monotherapy. The patient was diagnosed with stage 4 high-grade serous ovarian carcinoma and was treated with neoadjuvant chemotherapy, cytoreductive surgery, and postop...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngu, Siew-Fei, Ngan, Hextan Y. S., Chan, Karen K. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511802/
https://www.ncbi.nlm.nih.gov/pubmed/36176748
http://dx.doi.org/10.20517/cdr.2022.12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511802/
https://www.ncbi.nlm.nih.gov/pubmed/36176748
http://dx.doi.org/10.20517/cdr.2022.12

Ejemplares similares